MAP3K13-232aa was further detected in GC and corresponding adjacent non-neoplastic tissues, being highly expressed in 88.9% (8/9) of adjacent normal tissues but relatively reduced in GC tissues, consistent with the qPCR findings (Figs. 4C, 2E). This evidence concerns the gene MAP3K13 and gastric cancer.